Haichen Pharmaceutical (300584.SZ) plans to acquire minority shareholders' shares in Anqing Huichen

According to Zhitong Finance App, Haichen Pharmaceutical (300584.SZ) announced that Gu Yuqin, Qian Demin, Lu Shiping and Jiang Jinyuan, minority shareholders of Anqing Huichen Technology Co., Ltd. (hereinafter referred to as “Anqing Huichen” or “Huichen Technology”), the holding subsidiary of the company, intend to transfer 25% of their total shares in Anqing Huichen. The company plans to acquire a total of 10.00% of Anqing Huichen's shares held by Gu Yuqin, Qian Demin, and Lu Shiping at a price of 64.5083 million yuan, and to acquire 15.00% of Anqing Huichen's shares held by Jiang Jinyuan at a price of 0 yuan. After the acquisition is completed, the company's shareholding ratio in Anqing Huichen will increase from 75% to 100%, and Anqing Huichen will become a wholly-owned subsidiary of the company.

With the steady commissioning and supply of Anqing Huichen electrolyte additives, the new energy materials business segment has become a new engine for the company's business development and performance growth. The company's acquisition of minority shareholders' shares in Anqing Huichen this time is conducive to improving the management decision-making efficiency and core competitiveness of the company's business in this sector, fully unleashing the collaborative value between listed companies and various subsidiaries. At the same time, as Anqing Huichen's operating income and profit scale gradually increases, increasing the shareholding ratio in Anqing Huichen will help enhance the company's performance and is in line with the interests of the company and shareholders.